Researcher Profiles

Return to member profile

Xi Zheng, PhD

Publications since 2011

Huang, H. He, Y. Cui, X. X. Goodin, S. Wang, H. Du, Z. Y. Li, D. Zhang, K. Tony Kong, A. N. DiPaola, R. S. Yang, C. S. Conney, A. H. Zheng, X. Potent Inhibitory Effect of delta-Tocopherol on Prostate Cancer Cells Cultured in Vitro and Grown As Xenograft Tumors in Vivo. J Agric Food Chem, 62:10752-10758, . (PMID: 25322450)

Zhou, D. Y. Ding, N. Du, Z. Y. Cui, X. X. Wang, H. Wei, X. C. Conney, A. H. Zhang, K. Zheng, X. Curcumin analogues with high activity for inhibiting human prostate cancer cell growth and androgen receptor activation. Mol Med Rep, 10:1315-1322, . (PMID: 25060817)

Huang, H. Cui, X. X. Chen, S. Goodin, S. Liu, Y. He, Y. Li, D. Wang, H. VAN Doren, J. Dipaola, R. S. Conney, A. H. Zheng, X. Combination of Lipitor and Celebrex Inhibits Prostate Cancer VCaP Cells In Vitro and In Vivo. Anticancer Res, 34:3357-3363, . (PMID: 24982340)

Ding, N. Cui, X. X. Gao, Z. Huang, H. Wei, X. Du, Z. Lin, Y. Shih, W. J. Rabson, A. B. Conney, A. H. Hu, C. Zheng, X. A triple combination of atorvastatin, celecoxib and tipifarnib strongly inhibits pancreatic cancer cells and xenograft pancreatic tumors. Int J Oncol, 44:2139-2145, . (PMID: 24647860, PMCID: PMC4063540)

Wang, H. Cui, X. X. Goodin, S. Ding, N. Van Doren, J. Du, Z. Huang, M. T. Liu, Y. Cheng, X. Dipaola, R. S. Conney, A. H. Zheng, X. Inhibition of IL-6 expression in LNCaP prostate cancer cells by a combination of atorvastatin and celecoxib. Oncol Rep, 31:835-841, . (PMID: 24296978, PMCID: PMC3981114)

Zhou, D. Y. Zhang, K. Conney, A. H. Ding, N. Cui, X. X. Wang, H. Verano, M. Zhao, S. Q. Fan, Y. X. Zheng, X. Du, Z. Y. Synthesis and evaluation of curcumin-related compounds containing benzyl piperidone for their effects on human cancer cells. Chem Pharm Bull (Tokyo), In process, . (PMID: 23985704)

Du, Z. Y. Wei, X. Huang, M. T. Zheng, X. Liu, Y. Conney, A. H. Zhang, K. Anti-proliferative, anti-inflammatory and antioxidant effects of curcumin analogue A Arch Pharm Res, In process, . (PMID: 23888334)

Wei, X. Zhou, D. Wang, H. Ding, N. Cui, X. X. Wang, H. Verano, M. Zhang, K. Conney, A. H. Zheng, X. DU, Z. Y. Effects of Pyridine Analogs of Curcumin on Growth, Apoptosis and NF-kappaB Activity in Prostate Cancer PC-3 Cells. Anticancer Res, 33:1343-1350, . (PMID: 23564771)

Jiang, Y. Du, Z. Xue, G. Chen, Q. Lu, Y. Zheng, X. Conney, A. H. Zhang, K. Synthesis and biological evaluation of unsymmetrical curcumin analogues as tyrosinase inhibitors. Molecules, 18:3948-3961, . (PMID: 23552906)

Zheng, X. Cui, X. X. Gao, Z. Verano, M. Huang, M. T. Liu, Y. Rabson, A. B. Conney, A. H. Effects of 12-O-tetradecanoylphorbol-13-acetate in combination with gemcitabine on Panc-1 pancreatic cancer cells cultured in vitro or Panc-1 tumors grown in immunodeficient mice. Int J Oncol, 41:2269-2275, . (PMID: 23041978)

Wei, X. DU, Z. Y. Cui, X. X. Verano, M. Mo, R. Q. Tang, Z. K. Conney, A. H. Zheng, X. Zhang, K. Effects of cyclohexanone analogues of curcumin on growth, apoptosis and NF-kappaB activity in PC-3 human prostate cancer cells. Oncol Lett, 4:279-284, . (PMID: 22844370, PMCID: PMC3402731)

Wei, X. Du, Z. Y. Zheng, X. Cui, X. X. Conney, A. H. Zhang, K. Synthesis and evaluation of curcumin-related compounds for anticancer activity. Eur J Med Chem, 53:235-245, . (PMID: 22551677)

Du, Z. Qin, B. Sun, C. Liu, Y. Zheng, X. Zhang, K. Conney, A. H. Zeng, H. Folding-promoted TBAX-mediated selective demethylation of methoxybenzene-based macrocyclic aromatic pentamers. Org Biomol Chem, 10:4164-4171, . (PMID: 22456627)

Zheng, X. Cui, X. X. Huang, M. T. Liu, Y. Wagner, G. C. Lin, Y. Shih, W. J. Lee, M. J. Yang, C. S. Conney, A. H. Inhibition of Progression of Androgen-Dependent Prostate LNCaP Tumors to Androgen Independence in SCID Mice by Oral Caffeine and Voluntary Exercise. Nutr Cancer, 64:1029-1037, . (PMID: 23061906)

So, J. Y. Lee, H. J. Smolarek, A. K. Paul, S. Wang, C. X. Maehr, H. Uskokovic, M. Zheng, X. Conney, A. H. Cai, L. Liu, F. Suh, N. A novel Gemini vitamin D analog represses the expression of a stem cell marker CD44 in breast cancer. Mol Pharmacol, 79:360-367, . (PMID: 21115634, PMCID: PMC3061370)

Zheng, X. Cui, X. X. Gao, Z. Zhao, Y. Shi, Y. Huang, M. T. Liu, Y. Wagner, G. C. Lin, Y. Shih, W. J. Rao, C. V. Yang, C. S. Conney, A. H. Inhibitory effect of dietary atorvastatin and celecoxib together with voluntary running wheel exercise on the progression of androgen-dependent LNCaP prostate tumors to androgen independence. Exp Ther Med, 2:221-228, . (PMID: 21660218, PMCID: PMC3109910)

Zheng, X. Cui, X. X. Khor, T. O. Huang, Y. Dipaola, R. S. Goodin, S. Lee, M. J. Yang, C. S. Kong, A. N. Conney, A. H. Inhibitory Effect of a gamma-Tocopherol-Rich Mixture of Tocopherols on the Formation and Growth of LNCaP Prostate Tumors in Immunodeficient Mice. Cancers (Basel), 3:3762-3772, . (PMID: 24213110, PMCID: PMC3763395)